TDP2 and non-small cell lung carcinoma: In this context, TDP2 expression is reportedly elevated in the majority of non-small cell lung cancer cells [43], and mutant-p53-dependent over-expression of TDP2 has been implicated in cellular resistance to etoposide in lung cancer cells [44].